UPDATED – 2022 Safety Protocols

CHI has instituted mandatory health and safety protocols for all in-person participants. We are excited to bring our community back together in 2022, with trust and safety as our top priorities. All in-person participants are required to:

  • Provide proof of full vaccination against COVID-19. You will be asked to present your vaccination card (or a photo of it) at registration.
  • Have a negative COVID-19 test result from an FDA-authorized, a WHO-authorized, or European authorized over-the-counter antigen test within 24 hours prior to arriving at the event. You will be asked your results at registration.
×

Don't Miss a Minute of Immuno-Oncology Summit Europe

Access Event Platform

Registered attendees, speakers, sponsors and exhibitors were provided access through an email from our virtual event platform pathable.com. If you haven’t received your access email, contact us now.

Haven’t registered yet? There is still time.


About the Immuno-Oncology Summit Europe

CHI’s Sixth Annual Immuno-Oncology Summit Europe returns to London’s Canary Wharf for three packed days of science and technology, discussion and networking, with coverage of recent advances in the development of promising immuno-oncology treatments. The event is comprised of three conference programs that cover therapeutic categories; T-Cell and related Cellular Therapeutics, Bi-specific Antibodies and Therapies targeting the Tumour Microenvironment, while a fourth program covers strategies for Therapeutic Development, including Predictive Biomarkers, Preclinical studies and Translational Studies. Clinical results and combination therapies will also be highlighted.



Plenary Keynote Speakers

Dario Neri, PhD

Dario Neri, PhD
Philogen

Sergio A. Quezada, PhD

Sergio A. Quezada, PhD
University College London

Claire Roddie, PhD

Claire Roddie, PhD
UCL Cancer Institute

Roy Baynes, MD, PhD

Roy Baynes, MD, PhD
Merck, Sharp, and Dohme


Featured Speakers

Ruud de Wildt, Ph.D.

Ruud de Wildt, Ph.D.
GSK

Sophia N. Karagiannis, BA, MS, PhD

Sophia N. Karagiannis, BA, MS, PhD
King's College London

Marina Bacac, PhD

Marina Bacac, PhD
Roche Innovation Center Zurich

Sam Hanash, MD

Sam Hanash, MD
Anderson

Richard Stebbings

Richard Stebbings
AstraZeneca

Christine Trumpfheller

Christine Trumpfheller
Roche Innovation Centre

Francesco Marincola, MD

Francesco Marincola, MD
Kite Pharma

Andrew Sewell, PhD

Andrew Sewell, PhD
Cardiff University School of Medicine

Howard Goodall, MBChB

Howard Goodall, MBChB
Immunocore

Zhen Su

Zhen Su
Marengo Therapeutics

Robert Wilkinson

Robert Wilkinson
AstraZeneca

Eric Smith

Eric Smith
Regeneron



Connect With Us

MEETING SUGGESTIONS

For meeting questions or suggestions, please contact:

Phillips Kuhl
President
Cambridge Innovation Institute
pkuhl@healthtech.com

PARTNERING & SPONSORSHIP

For partnering and sponsorship info, please contact:

Rod Eymael
Manager, Business Development
Cambridge Healthtech Institute
+1 781.247.6286
reymael@healthtech.com

MEDIA & ASSOCIATION

For media and association partnerships, please contact:

Christine Benners
Sr. Marketing Manager
Cambridge Healthtech Institute
+1 781.247.1820
cbenners@healthtech.com